Association of coffee and caffeine intake with the risk of Parkinson disease.

CONTEXT The projected expansion in the next several decades of the elderly population at highest risk for Parkinson disease (PD) makes identification of factors that promote or prevent the disease an important goal. OBJECTIVE To explore the association of coffee and dietary caffeine intake with risk of PD. DESIGN, SETTING, AND PARTICIPANTS Data were analyzed from 30 years of follow-up of 8004 Japanese-American men (aged 45-68 years) enrolled in the prospective longitudinal Honolulu Heart Program between 1965 and 1968. MAIN OUTCOME MEASURE Incident PD, by amount of coffee intake (measured at study enrollment and 6-year follow-up) and by total dietary caffeine intake (measured at enrollment). RESULTS During follow-up, 102 men were identified as having PD. Age-adjusted incidence of PD declined consistently with increased amounts of coffee intake, from 10.4 per 10,000 person-years in men who drank no coffee to 1.9 per 10,000 person-years in men who drank at least 28 oz/d (P<.001 for trend). Similar relationships were observed with total caffeine intake (P<.001 for trend) and caffeine from non-coffee sources (P=.03 for trend). Consumption of increasing amounts of coffee was also associated with lower risk of PD in men who were never, past, and current smokers at baseline (P=.049, P=.22, and P=.02, respectively, for trend). Other nutrients in coffee, including niacin, were unrelated to PD incidence. The relationship between caffeine and PD was unaltered by intake of milk and sugar. CONCLUSIONS Our findings indicate that higher coffee and caffeine intake is associated with a significantly lower incidence of PD. This effect appears to be independent of smoking. The data suggest that the mechanism is related to caffeine intake and not to other nutrients contained in coffee. JAMA. 2000;283:2674-2679.

[1]  Ward Cd,et al.  Research diagnostic criteria for Parkinson's disease. , 1990 .

[2]  D J Foley,et al.  Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.

[3]  Daniel L. McGee,et al.  Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. , 1984, American journal of epidemiology.

[4]  H. Watanabe,et al.  Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors , 1986, Neuropharmacology.

[5]  D. Morens,et al.  Epidemiologic observations on Parkinson's disease , 1996, Neurology.

[6]  D. Reed,et al.  Coffee, caffeine, and serum cholesterol in Japanese men in Hawaii. , 1986, American journal of epidemiology.

[7]  L. Heilbrun,et al.  The origins of epidemiologic studies of heart disease, cancer and osteoporosis among Hawaii Japanese. , 1985, Hawaii medical journal.

[8]  J. Hankin,et al.  Within-person variability of nutrient intake in a group of Hawaiian men of Japanese ancestry. , 1982, The American journal of clinical nutrition.

[9]  P. Jenner,et al.  Adenosine A2A receptors modify motor function in MPTP‐treated common marmosets , 1998, Neuroreport.

[10]  I. Shoulson,et al.  Studies with bromocriptine , 1976, Neurology.

[11]  D. Morens,et al.  Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. , 1994, American journal of epidemiology.

[12]  P. W. Lane,et al.  Analysis of covariance and standardization as instances of prediction. , 1982, Biometrics.

[13]  D. Calne,et al.  Assessment of Parkinson's Disease , 1984, Clinical neuropharmacology.

[14]  C. Tanner Epidemiology of Parkinson’s Disease , 1992, Neurologic Clinics.

[15]  M. Caporali,et al.  Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility , 1991, The Journal of pharmacy and pharmacology.

[16]  D.,et al.  Regression Models and Life-Tables , 2022 .

[17]  I. Shoulson,et al.  Caffeine and the antiparkinsonian response to levodopa or piribedil , 1975, Neurology.

[18]  R. Worth,et al.  Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. , 1970, Journal of chronic diseases.

[19]  J. Langston,et al.  Epidemiology versus genetics in parkinson's disease: Progress in resolving an age‐old debate , 1998, Annals of neurology.

[20]  J. Málly,et al.  The effect of theophylline on parkinsonian symptoms , 1994, The Journal of pharmacy and pharmacology.

[21]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[22]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[23]  G. Ulm,et al.  Diet and Parkinson's disease II , 1996, Neurology.

[24]  D. Mateo,et al.  Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case‐control study , 1992, Movement disorders : official journal of the Movement Disorder Society.

[25]  G. Román,et al.  Worldwide occurrence of Parkinson's disease: an updated review. , 1993, Neuroepidemiology.

[26]  Langston Jw Epidemiology versus genetics in parkinson's disease: Progress in resolving an age-old debate , 1998 .

[27]  Astrid Nehlig,et al.  Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects , 1992, Brain Research Reviews.

[28]  O. Axelson,et al.  Nutritional and occupational factors influencing the risk of Parkinson's disease: A case‐control study in southeastern Sweden , 1999, Movement disorders : official journal of the Movement Disorder Society.

[29]  M. Nefzger,et al.  A retrospective study of smoking in Parkinson's disease. , 1968, American journal of epidemiology.

[30]  P. Jenner,et al.  Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. , 1997, Trends in pharmacological sciences.